Comparisons
The comparison every buyer makes before choosing
12 head-to-head pages on the peptide pairs people actually weigh against each other, each one graded on what the human evidence covers rather than what a clinic menu implies.
All comparisons
BPC-157 vs KPV
Two unrelated fragments of two unrelated proteins, sold on the same gut-and-inflammation story, with laboratory files where a human trial base should be.
BPC-157 vs TB-500
Two different molecules from two different biological stories, sold side by side on the strength of animal research, with no controlled human trial base behind either one.
CJC-1295 vs ipamorelin
These two are rarely a real choice, because the market sells them together — and the pairing that makes pharmacological sense has never been tested for the results it is sold on.
Injectable GHK-Cu vs copper peptide topicals
The human evidence in this category belongs to creams, and the injectable vial is being sold on the strength of it.
MOTS-c vs Epitalon
Two peptides sold on the same longevity promise from opposite ends of the evidence scale. One the body makes and researchers can measure; the other’s human literature is mostly about a different substance.
NAD+ injection vs NAD+ IV
These are two ways of presenting the body with a molecule it takes apart before any cell uses it, and neither route has the outcome evidence the category is sold on.
NAD+ vs glutathione
Two unrelated molecules that share a drip menu and one awkward property: neither enters a cell intact, so what is being bought is raw material rather than the molecule on the label.
Sermorelin vs CJC-1295
Both act on the same receptor, and the real difference is that sermorelin is one molecule with a regulatory past while CJC-1295 is one name covering two molecules with different durations.
Sermorelin vs growth hormone
Growth hormone is an approved drug with defined indications, and sermorelin is a compounded upstream signal — not two strengths of one treatment, and neither tested against the anti-aging outcomes both are marketed on.
Sermorelin vs ipamorelin
The two compounds reach the same hormone through two different receptors, and neither has been tested against the results healthy adults are sold on.
Sermorelin vs tesamorelin
Tesamorelin cleared a real trial bar for a defined indication in a defined population, which is not the anti-aging use both compounds are now sold on.
Tesamorelin vs CJC-1295
Two analogues of the same hormone with two very different human files: one was carried through controlled trials to an approval, and the other was measured for what it does to a blood level.